Human Genome Sciences Benlysta Drug Approval for Lupus Patients

Human Genome Sciences Benlysta Drug Approval for Lupus Patie...

StockMarketFunding

Share:
Share:
New Break through in Human Genome Sciences Benlysta drug approval for lupus patients. SMF will cover the pros and the cons of the HGSI new drug and benefits to humanity. We will take a look at one of the most positive developments in "biotechnology" in the past 50 years. We have highlighted HGSI and the longer term trends relative to the current drug developments. BENLYSTA is an investigational human monoclonal antibody drug. It is the first in a...Read More
New Break through in Human Genome Sciences Benlysta drug approval for lupus patients. SMF ...Read More